|
1
|
Wouters BJ and Delwel R: Epigenetics and
approaches to targeted epigenetic therapy in acute myeloid
leukemia. Blood. 127:42–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burnett A, Wetzler M and Lowenberg B:
Therapeutic advances in acute myeloid leukemia. J Clin Oncol.
29:487–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao W and Estey E: Moving toward targeted
therapies in acute myeloid leukemia. Clin Adv Hematol Oncol.
13:748–754. 2015.PubMed/NCBI
|
|
4
|
Ramos P and Bentires-Alj M:
Mechanism-based cancer therapy: Resistance to therapy, therapy for
resistance. Oncogene. 34:3617–3626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones PM and George AM: The ABC
transporter structure and mechanism: Perspectives on recent
research. Cell Mol Life Sci. 61:682–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borst P, Evers R, Kool M and Wijnholds J:
A family of drug transporters: The multidrug resistance-associated
proteins. J Natl Cancer Inst. 92:1295–1302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bodor M, Kelly EJ and Ho RJ:
Characterization of the human MDR1 gene. AAPS J. 7:E1–E5. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambudkar SV, Dey S, Hrycyna CA,
Ramachandra M, Pastan I and Gottesman MM: Biochemical, cellular,
and pharmacological aspects of the multidrug transporter. Annu Rev
Pharmacol Toxicol. 39:361–398. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abraham J, Salama NN and Azab AK: The role
of P-glycoprotein in drug resistance in multiple myeloma. Leuk
Lymphoma. 56:26–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Delbridge AR and Strasser A: The BCL-2
protein family, BH3-mimetics and cancer therapy. Cell Death Differ.
22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng JH, Viacava Follis A, Kriwacki RW
and Moldoveanu T: Discoveries and controversies in BCL-2
protein-mediated apoptosis. FEBS J. 283:2690–2700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghibelli L and Diederich M: Multistep and
multitask bax activation. Mitochondrion. 10:604–613. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kvansakul M and Hinds MG: The Bcl-2
family: Structures, interactions and targets for drug discovery.
Apoptosis. 20:136–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Indran IR, Tufo G, Pervaiz S and Brenner
C: Recent advances in apoptosis, mitochondria and drug resistance
in cancer cells. Biochim Biophys Acta. 1807:735–745. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhi X, Feng W, Rong Y and Liu R: Anatomy
of autophagy: From the beginning to the end. Cell Mol Life Sci.
75:815–831. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Budini M, Buratti E, Morselli E and
Criollo A: Autophagy and its impact on neurodegenerative diseases:
New roles for TDP-43 and C9orf72. Front Mol Neurosci. 10:1702017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morandi E, Jagessar SA, t Hart BA and Gran
B: EBV infection empowers human b cells for autoimmunity: Role of
autophagy and relevance to multiple sclerosis. J Immunol.
199:435–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cosin-Roger J, Simmen S, Melhem H, Atrott
K, Frey-Wagner I, Hausmann M, de Vallière C, Spalinger MR,
Spielmann P, Wenger RH, et al: Hypoxia ameliorates intestinal
inflammation through NLRP3/mTOR downregulation and autophagy
activation. Nat Commun. 8:982017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fulda S: Autophagy in cancer therapy.
Front Oncol. 7:1282017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gewirtz DA: The four faces of autophagy:
Implications for cancer therapy. Cancer Res. 74:647–651. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puissant A, Robert G, Fenouille N, Luciano
F, Cassuto JP, Raynaud S and Auberger P: Resveratrol promotes
autophagic cell death in chronic myelogenous leukemia cells via
JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res.
70:1042–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang F, Chen J, Zhang Z, Yi J, Yuan M,
Wang M, Zhang N, Qiu X, Wei H and Wang L: Differences of basic and
induced autophagic activity between K562 and K562/ADM cells.
Intractable Rare Dis Res. 6:281–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu K, Liu PC, Liu R and Wu X: Dual AO/EB
staining to detect apoptosis in osteosarcoma cells compared with
flow cytometry. Med Sci Monit Basic Res. 21:15–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daver N, Cortes J, Kantarjian H and
Ravandi F: Acute myeloid leukemia: Advancing clinical trials and
promising therapeutics. Expert Rev Hematol. 9:433–445. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Plasschaert SL, de Bont ES, Boezen M,
vander Kolk DM, Daenen SM, Faber KN, Kamps WA, de Vries EG and
Vellenga E: Expression of multidrug resistance-associated proteins
predicts prognosis in childhood and adult acute lymphoblastic
leukemia. Clin Cancer Res. 11:8661–8668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Wei H, Xie B, Wang B and Cheng J
and Cheng J: Endoplasmic reticulum stress contributes to arsenic
trioxide-induced apoptosis in drug-sensitive and -resistant
leukemia cells. Leuk Res. 36:1526–1535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li CL, Wei HL, Chen J, Wang B, Xie B, Fan
LL and Li LJ: Arsenic trioxide induces autophagy and antitumor
effects in burkitt's lymphoma raji cells. Oncol Rep. 32:1557–1563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han W, Sun J, Feng L, Wang K, Li D, Pan Q,
Chen Y, Jin W, Wang X, Pan H and Jin H: Autophagy inhibition
enhances daunorubicin-induced apoptosis in K562 cells. PLoS One.
6:e284912011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Riz I, Hawley TS and Hawley RG:
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to
carfilzomib resistance in multiple myeloma models. Oncotarget.
6:14814–14831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun Q, Liu T, Yuan Y, Guo Z, Xie G, Du S,
Lin X, Xu Z, Liu M, Wang W, et al: MiR-200c inhibits autophagy and
enhances radiosensitivity in breast cancer cells by targeting
UBQLN1. Int J Cancer. 136:1003–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang H, Tang J, Li C, Kong J, Wang J, Wu
Y, Xu E and Lai M: MiR-22 regulates 5-FU sensitivity by inhibiting
autophagy and promoting apoptosis in colorectal cancer cells.
Cancer Lett. 356:781–790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim SH, Kim KY, Yu SN, Park SK, Choi HD,
Ji JH and Ahn SC: Autophagy inhibition enhances silibinin-induced
apoptosis by regulating reactive oxygen species production in human
prostate cancer PC-3 cells. Biochem Biophys Res Commun.
468:151–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li CL, Wei HL, Chen J, Wang B, Xie B, Fan
LL and Li LJ: Ebb-and-flow of macroautophagy and chaperone-mediated
autophagy in raji cells induced by starvation and arsenic trioxide.
Asian Pac J Cancer Prev. 15:5715–5719. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Caminal-Montero L and Suárez-Díaz S:
Hydroxychloroquine and antimalarials. J Rheumatol.
15:jrheum.190559. 2019.
|
|
41
|
Zhang H, Han D, Lv T, Liu K, Yang Y, Xu X
and Chen Y: Novel peptide myristoly-CM4 induces selective
cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis
and/or apoptosis pathway. Drug Des Devel Ther. 13:2153–2167. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: P38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oral O, Akkoc Y, Bayraktar O and Gozuacik
D: Physiological and pathological significance of the molecular
cross-talk between autophagy and apoptosis. Histol Histopathol.
31:479–498. 2016.PubMed/NCBI
|
|
44
|
Zhou Y, Sun K, Ma Y, Yang H, Zhang Y, Kong
X and Wei L: Autophagy inhibits chemotherapy-induced apoptosis
through downregulating bad and bim in hepatocellular carcinoma
cells. Sci Rep. 4:53822014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yuan N, Song L, Zhang S, Lin W, Cao Y, Xu
F, Fang Y, Wang Z, Zhang H, Li X, et al: Bafilomycin A1 targets
both autophagy and apoptosis pathways in pediatric B-cell acute
lymphoblastic leukemia. Haematologica. 100:345–356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rees DC, Johnson E and Lewinson O: ABC
transporters: The power to change. Nat Rev Mol Cell Biol.
10:218–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Breier A, Gibalova L, Seres M, Barancik M
and Sulova Z: New insight into p-glycoprotein as a drug target.
Anticancer Agents Med Chem. 13:159–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Silva R, Vilas-Boas V, Carmo H,
Dinis-Oliveira RJ, Carvalho F, de Lourdes Bastos M and Remiao F:
Modulation of P-glycoprotein efflux pump: Induction and activation
as a therapeutic strategy. Pharmacol Ther. 149:1–123. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang LH, Yang AJ, Wang M, Liu W, Wang CY,
Xie XF, Chen X, Dong JF and Li M: Enhanced autophagy reveals
vulnerability of P-gp mediated epirubicin resistance in triple
negative breast cancer cells. Apoptosis. 21:473–488. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun WL, Lan D, Gan TQ and Cai ZW:
Autophagy facilitates multidrug resistance development through
inhibition of apoptosis in breast cancer cells. Neoplasma.
62:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu W, Meng Q, Sun Y, Wang C, Huo X, Liu
Z, Sun P, Sun H, Ma X and Liu K: Targeting P-Glycoprotein:
Nelfinavir reverses adriamycin resistance in K562/ADR cells. Cell
Physiol Biochem. 51:1616–1631. 2018. View Article : Google Scholar : PubMed/NCBI
|
